Product Code: RP-ID-10336407 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10336407
Market Overview:
Impact Analysis of COVID-19 on Global and Southeast Asia Protein Purification Isolation Market Outlook 2030
Global & Southeast Asia Protein Purification & Isolation Market Analysis 2019-2030
Protein purification is defined as the series of processes for the isolation of a single type of protein from a complex mixture. In many experiments, protein isolation and purification process is one of the first steps which is useful in the determination of protein structure or any biological activity. The global and southeast Asia protein purification & isolation market is anticipated to achieve a CAGR of 8.65% across the globe during the forecast period, i.e. 2021-2030. Factors such as the increasing investments by the leading protein purification and isolation companies for research and development projects, increasing investments made by the companies for acquisitions and collaborations, increasing adoption of protein purification and isolation solutions, rising demand for rapid purification kits for rapidly preparing, screening, purifying, and concentrating protein samples, increasing research activities in the pharmaceutical and biotechnological fields, and the growing need to identify new protein-based drug molecules are anticipated to promote towards the growth of the global and southeast Asia protein purification & isolation market. Additionally, factors such as the growing need amongst researchers and laboratory analysts to reduce the contamination during the extraction and isolation process of proteins, which in turn is raising the need for more accurate and purification kit, is anticipated to drive the growth of the global and southeast Asia protein purification & isolation market.
The global and southeast Asia protein purification & isolation market consists of various segments that are segmented by product, technology and by region. The technology segment is further divided into ultrafiltration, precipitation, chromatography, electrophoresis, western blotting and others. Out of these, the chromatography segment registered the largest market share of around 27% in the year 2019 and is expected to grow at a CAGR of around 9% during the forecast period. The segment is further anticipated to cross a value of around USD 4200.0 million by the end of 2030. Chromatography uses the principle of phase equilibrium partitioning for the separation of nucleic acids, proteins, or small molecules in complex mixtures based on their differing interactions with a stationary phase and a mobile phase. Various types of chromatography processes that are used for protein purification and isolation are ION exchange chromatography, reversed phase chromatography, affinity chromatography, size exclusion chromatography and hydrophobic interaction chromatography (HIC) among others.
Based on region, the global and southeast Asia protein purification & isolation market is segmented into six major regions including North America, Latin America, Europe, Asia Pacific, South East Asia and Middle East and Africa. The market in Europe registered a significant market share along with a value of around USD 1450 million in the year 2019 and is expected to cross a value of around USD 3600 million by the end of 2030 by growing at a CAGR of around 8.60% during the forecast period. Increasing research and developmental activities in the region, coupled with the growing expenditure on healthcare and the changing environment conditions and increasing number of diseases are some of the factors anticipated to drive the growth of the market in Europe.
Some of the affluent industry leaders in the global and southeast Asia protein purification & isolation market are Thermo Fisher Scientific Inc., Merck KGaA, Sigma-Aldrich Co., QIAGEN GmbH, Bio-Rad Laboratories, Inc., Agilent Technologies, General Electric Company, Abcam plc and F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc., Merck KGaA, Sigma-Aldrich Co., QIAGEN GmbH, Bio-Rad Laboratories, Inc., Agilent Technologies, General Electric Company, Abcam plc and F. Hoffmann-La Roche Ltd.
Related Reports
Proof of Quality & Reliability
